Seminars in Spine Surgery
Volume 21, Issue 2 , Pages 121-128 , June 2009

Radiotherapy for Primary and Metastatic Spinal Tumors

  • O. Kenneth Macdonald, MD

      Affiliations

    • Department of Radiation Oncology, Mayo Clinic, Rochester, MN
    • Corresponding Author InformationAddress reprint requests to O. Kenneth Macdonald, MD, Department of Radiation Oncology, Mayo Clinic, Desk R, Charlton Subway Level, 200 First St. SW, Rochester, MN 55905
    • ,
  • Christopher M. Lee, MD

      Affiliations

    • Department of Radiation Oncology, Cancer Care Northwest, Spokane, WA

References 

  1. Erlemann R. Imaging and differential diagnosis of primary bone tumors and tumor-like lesions of the spine. Eur J Radiol. 2006;58:48–67
  2. Fisher CG, Keynan O, Boyd MC, et al. The surgical management of primary tumors of the spine: Initial results of an ongoing prospective cohort study. Spine. 2005;30:1899–1908
  3. Flemming DJ, Murphey MD, Carmichael BB, et al. Primary tumors of the spine. Semin Musculoskelet Radiol. 2000;4:299–320
  4. Leone A, Costantini A, Guglielmi G, et al. Primary bone tumors and pseudotumors of the lumbosacral spine. Rays. 2000;25:89–103
  5. Rodallec MH, Feydy A, Larousserie F, et al. Diagnostic imaging of solitary tumors of the spine: What to do and say. Radiographics. 2008;28:1019–1041
  6. Taiji K, Takahiro H, Takahiro G. Bone diseases with pain (Primary bone tumors of the spine). Clin Calcium. 2007;17:1435–1440
  7. Hatrick NC, Lucas JD, Timothy AR, et al. The surgical treatment of metastatic disease of the spine. Radiother Oncol. 2000;56:335–339
  8. Gokaslan ZL, York JE, Walsh GL, et al. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg. 1998;89:599–609
  9. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: An overview. Neurosurg Focus. 2001;11:e10
  10. Barton R, Robinson G, Gutierrez E, et al. Palliative radiation for vertebral metastases: The effect of variation in prescription parameters on the dose received at depth. Int J Radiat Oncol Biol Phys. 2002;52:1083–1091
  11. Bilsky MH. New therapeutics in spine metastases. Exp Rev Neurother. 2005;5:831–840
  12. Chi JH, Gokaslan ZL. Vertebroplasty and kyphoplasty for spinal metastases. Curr Opin Support J Palliat Care. 2008;2:9–13
  13. Preciado DA, Sebring LA, Adams GL. Treatment of patients with spinal metastases from head and neck neoplasms. Arch Otolaryngol Head Neck Surg. 2002;128:539–543
  14. Rao G, Ha CS, Chakrabarti I, et al. Multiple myeloma of the cervical spine: Treatment strategies for pain and spinal instability. J Neurosurg Spine. 2006;5:140–145
  15. Ruckdeschel JC. Early detection and treatment of spinal cord compression. Oncol Williston Park. 2005;19:81–86discussion, 86, 89-92
  16. Sciubba DM, Nguyen T, Gokaslan ZL. Solitary vertebral metastasis. Orthop Clin North Am. 2009;40:145–154
  17. Selvaggi K, Abrahm J. Metastatic spinal cord compression: The hidden danger. Nat Clin Pract Oncol. 2006;3:458–461quiz following 461
  18. Swift PS. Radiation for spinal metastatic tumors. Orthop Clin North Am. 2009;40:133–144
  19. Cheung G, Chow E, Holden L, et al. Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: A prospective study using quality-of-life assessment. Can Assoc Radiol J. 2006;57:13–21
  20. Gok B, McGirt M, Sciubba DM, et al. Surgical resection plus adjuvant radiotherapy is superior to surgery or radiotherapy alone in the prevention of neurological decline in a rat metastatic spinal tumor model. Neurosurgery. 2008;63:346–351discussion 351
  21. Healey JH, Brown HK. Complications of bone metastases: Surgical management. Cancer. 2000;88:2940–2951
  22. Khan SN, Donthineni R. Surgical management of metastatic spine tumors. Orthop Clin North Am. 2006;37:99–104
  23. Tai PT, Craighead P, Bagdon F. Optimization of radiotherapy for patients with cranial chordoma (A review of dose–response ratios for photon techniques). Cancer. 1995;75:749–756
  24. Wold LE, Laws ER. Cranial chordomas in children and young adults. J Neurosurg. 1983;59:1043–1047
  25. Kaiser TE, Pritchard DJ, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984;53:2574–2578
  26. al-Mefty O, Borba LA. Skull base chordomas: A management challenge. J Neurosurg. 1997;86:182–189
  27. Catton C, O'Sullivan B, Bell R, et al. Chordoma: Long-term follow-up after radical photon irradiation. Radiother Oncol. 1996;41:67–72
  28. Cheng EY, Ozerdemoglu RA, Transfeldt EE, et al. Lumbosacral chordoma (Prognostic factors and treatment). Spine. 1999;24:1639–1645
  29. Debus J, Schulz-Ertner D, Schad L, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys. 2000;47:591–596
  30. Foweraker KL, Burton KE, Maynard SE, et al. High-dose radiotherapy in the management of chordoma and chondrosarcoma of the skull base and cervical spine (Part 1. Clinical outcomes). Clin Oncol (R Coll Radiol). 2007;19:509–516
  31. Noel G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine (Prognostic factors and patterns of failure). Strahlenther Onkol. 2003;179:241–248
  32. Igaki H, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys. 2004;60:1120–1126
  33. Nguyen QN, Chang EL. Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep. 2008;10:338–343
  34. Noel G, Feuvret L, Calugaru V, et al. Chordomas of the base of the skull and upper cervical spine (One hundred patients irradiated by a 3D conformal technique combining photon and proton beams). Acta Oncol. 2005;44:700–708
  35. Weber DC, Rutz HP, Pedroni ES, et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys. 2005;63:401–409
  36. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: An updated report. J Clin Oncol. 2000;18:4016–4027
  37. Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest. 2001;19:292–315
  38. Machak GN, Tkachev SI, Solovyev YN, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc. 2003;78:147–155
  39. Beck JC, Wara WM, Bovill EG, et al. The role of radiation therapy in the treatment of osteosarcoma. Radiology. 1976;120:163–165
  40. Jenkin RD, Allt WE, Fitzpatrick PJ. Osteosarcoma (An assessment of management with particular reference to primary irradiation and selective delayed amputation). Cancer. 1972;30:393–400
  41. Carrie C, Breteau N, Negrier S, et al. The role of fast neutron therapy in unresectable pelvic osteosarcoma: Preliminary report. Med Pediatr Oncol. 1994;22:355–357
  42. Lombardi F, Gandola L, Fossati-Bellani F, et al. Hypofractionated accelerated radiotherapy in osteogenic sarcoma. Int J Radiat Oncol Biol Phys. 1992;24:761–765
  43. Lichtenstein L, Jaffe HL. Chondrosarcomas of bone. Am J Pathol. 1943;19:553–589
  44. Marcove RC, Mike V, Hutter RV, et al. Chondrosarcoma of the pelvis and upper end of the femur (An analysis of factors influencing survival time in one hundred and thirteen cases). J Bone Joint Surg Am. 1972;54:561–572
  45. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432–439
  46. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57–63
  47. Rosenberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull: A clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23:1370–1378
  48. Hernandez JA, Land KJ, McKenna RW. Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer. 1995;75:381–394
  49. Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36:329–333
  50. Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: Outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:1063–1067
  51. Liebross RH, Ha CS, Cox JD, et al. Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol. 1999;52:245–249
  52. Mill WB, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer. 1980;45:647–652
  53. Ozsahin M, Tsang RW, Poortmans P, et al. Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys. 2006;64:210–217
  54. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50:113–120
  55. Wilder RB, Ha CS, Cox JD, et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer. 2002;94:1532–1537
  56. Adamietz IA, Schober C, Schulte RW, et al. Palliative radiotherapy in plasma cell myeloma. Radiother Oncol. 1991;20:111–116
  57. Leigh BR, Kurtts TA, Mack CF, et al. Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys. 1993;25:801–804
  58. Horning SJ, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2004;22:3032–3038
  59. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339:21–26
  60. Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: Analysis of 975 patients from the European InterGroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol. 2000;18:3108–3114
  61. La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: Results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys. 2006;64:544–550
  62. Carrie C, Mascard E, Gomez F, et al. Nonmetastatic pelvic Ewing' sarcoma: Report of the French society of pediatric oncology. Med Pediatr Oncol. 1999;33:444–449
  63. Donaldson SS, Torrey M, Link MP, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG # 8346 (Pediatric Oncology Group). Int J Radiat Oncol Biol Phys. 1998;42:125–135
  64. Sailer SL, Harmon DC, Mankin HJ, et al. Ewing's sarcoma: Surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys. 1988;15:43–52
  65. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the cess 81, cess 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys. 2003;55:168–177
  66. Yock TI, Krailo M, Fryer CJ, et al. Local control in pelvic Ewing' sarcoma: Analysis from INT-0091—A report from the Children's Oncology Group. J Clin Oncol. 2006;24:3838–3843
  67. Leddy ET. The roentgen treatment of metastasis to the vertebrae and the bones of the pelvis from carcinoma of the breast. AJR Am J Roentgenol. 1930;XXIV:657–672
  68. Agarawal JP, Swangsilpa T, van der Linden Y, et al. The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 2006;18:747–760
  69. Sze WM, Shelley M, Held I, et al. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy—A systematic review of the randomised trials. Cochrane Database Syst Rev. 2004;2:CD004721
  70. Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol. 2007;25:1423–1436
  71. Wu JS, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55:594–605
  72. Mithal NP, Needham PR, Hoskin PJ. Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys. 1994;29:1011–1014
  73. van der Linden YM, Steenland E, van Houwelingen HC, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: Results on survival in the Dutch Bone metastasis study. Radiother Oncol. 2006;78:245–253
  74. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The cancer care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol. 2005;23:2028–2037
  75. Perrin RG. Metastatic tumors of the axial spine. Curr Opin Oncol. 1992;4:525–532
  76. Sundaresan N, Galicich JH. Treatment of spinal metastases by vertebral body resection. Cancer Invest. 1984;2:383–397
  77. Laperriere NJ. The Management of Spinal Cord Compression. Toronto, ON, Canada: Princess Margaret Hospital; 1996;
  78. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet. 2005;366:643–648
  79. Sorensen S, Helweg-Larsen S, Mouridsen H, et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: A randomised trial. Eur J Cancer. 1994;30A:22–27
  80. Vecht CJ, Haaxma-Reiche H, van Putten WL, et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology. 1989;39:1255–1257
  81. Hoskin PJ, Grover A, Bhana R. Metastatic spinal cord compression: Radiotherapy outcome and dose fractionation. Radiother Oncol. 2003;68:175–180
  82. Maranzano E, Bellavita R, Rossi R, et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: Results of a phase III, randomized, multicenter trial. J Clin Oncol. 2005;23:3358–3365
  83. Rades D, Fehlauer F, Stalpers LJ, et al. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: Final results of a multicenter study. Cancer. 2004;101:2687–2692
  84. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005;23:3366–3375
  85. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer (A retrospective analysis of patients treated in the Nordic countries). Acta Oncol. 2006;45:787–795
  86. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94–S100
  87. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  88. Ryu S, Jin R, Jin JY, et al. Pain control by image-guided radiosurgery for solitary spinal metastasis. J Pain Symptom Manage. 2008;35:292–298
  89. Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7:151–160
  90. Gerszten PC, Burton SA, Ozhasoglu C, et al. Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution. Spine. 2007;32:193–199
  91. Samuel R, Yin FF, Rock J, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer. 2003;97:2013–2018
  92. Yamada Y, Bilsky MH, Lovelock DM, et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71:484–490
  93. Glimelius B, Ask A, Bjelkengren G, et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44:836–849
  94. Goitein M, Cox JD. Should randomized clinical trials be required for proton radiotherapy?. J Clin Oncol. 2008;26:175–176
  95. Lee CH, Tait D, Nahum AE, et al. Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol. 1999;72:1078–1084

PII: S1040-7383(09)00014-8

doi: 10.1053/j.semss.2009.03.006

Seminars in Spine Surgery
Volume 21, Issue 2 , Pages 121-128 , June 2009

Article Tools

* Image Usage & Resolution